Status:
UNKNOWN
Study With Rupatadine in Mosquito-Bite Allergic Adult Subjects
Lead Sponsor:
J. Uriach and Company
Conditions:
Allergy
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The study will find out how effective rupatadine is in the treatment of mosquito bite symptoms in adult patients allergic to mosquito bites.
Detailed Description
Mosquito-bite symptoms include wheals and pruritic bite papules. Oral antihistamines have shown to decrease whealing ang accompanying pruritus in placebo-controlled trials. Subjects will be treated f...
Eligibility Criteria
Inclusion
- Recent history of suffering from mosquito-bite reactions.
- At least 5 mm diameter mosquito-bite wheal from Aedes aegypti laboratory mosquitoes
Exclusion
- Pregnancy or lactating females
- Oral antihistamines, corticosteroids or non-steroid anti-inflammatory drugs (NSAID) use within two weeks before the study.
- Severe or moderate systemic illness
- Allergy to rupatadine or other antihistamines
- Anaphylaxis from mosquito bites
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00258141
Last Update
November 24 2005
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ulappatorin Lääkäriasema
Espoo, Finland
2
Koskiklinikka, Tampere Lääkärikeskus
Tampere, Finland, 33101